GRI Bio Inc (NASDAQ:GRI) has a beta value of -1.71 and has seen 1.72 million shares traded in the recent trading session. The company, currently valued at $1.37M, closed the recent trade at $0.47 per share which meant it gained $0.05 on the day or 11.56% during that session. The GRI stock price is -34363.83% off its 52-week high price of $161.98 and 14.89% above the 52-week low of $0.40. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.12 million shares traded. The 3-month trading volume is 602.49K shares.
GRI Bio Inc (NASDAQ:GRI) trade information
Sporting 11.56% in the green today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the GRI stock price touched $0.47 or saw a rise of 11.32%. Year-to-date, GRI Bio Inc shares have moved -98.66%, while the 5-day performance has seen it change -3.32%. Over the past 30 days, the shares of GRI Bio Inc (NASDAQ:GRI) have changed -7.86%. Short interest in the company has seen 0.44 million shares shorted with days to cover at 0.84.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
GRI Bio Inc (GRI) estimates and forecasts
The company’s shares have lost -95.35% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 26.64% over the past 5 years.
GRI Dividends
GRI Bio Inc is expected to release its next earnings report in October this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
GRI Bio Inc (NASDAQ:GRI)’s Major holders
Insiders own 0.35% of the company shares, while shares held by institutions stand at 9.79% with a share float percentage of 9.82%. Investors are also buoyed by the number of investors in a company, with GRI Bio Inc having a total of 6.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund. As of Jun 30, 2024, the former fund manager holds about 0.01% shares in the company for having 203.0 shares of worth $91.0 while later fund manager owns 158.0 shares of worth $71.0 as of Jul 31, 2024, which makes it owner of about 0.01% of company’s outstanding stock.
